SAN JUAN, Puerto Rico (AP) Merck announced Friday that it would cease active ingredient production at one of its plants in Puerto Rico in a blow to a city once considered a pharmaceutical hub.
The company said production at a plant in the north coastal city of Barceloneta will end by late 2014 as part of a global restructuring. Merck said formulation and packaging operations at that plant will continue under a third-party contract.
The company also will consolidate formulation operations at its plant in Arecibo with another plant in the eastern city of Las Piedras, with those operations being transferred to a third party by the end of 2016.
Cesar Simich, Merck's managing director for Puerto Rico and the Caribbean, told The Associated Press in a phone interview that it was too early to say how many people would lose their jobs as a result of the restructuring.
Simich noted the company has invested more than $100 million in recent years in its plant in Las Piedras, which is one of only two Merck facilities worldwide dedicated to developing and launching new products. He said updated manufacturing technologies will help the plant launch three new products.